SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-21-022601
Filing Date
2021-04-30
Accepted
2021-04-30 17:07:29
Documents
4
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A ljpc-10ka_20201231.htm 10-K/A 730897
2 EX-31.1 ljpc-ex311_33.htm EX-31.1 23076
3 EX-31.2 ljpc-ex312_32.htm EX-31.2 23056
4 EX-32.1 ljpc-ex321_30.htm EX-32.1 15725
  Complete submission text file 0001564590-21-022601.txt   793778
Mailing Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36282 | Film No.: 21879485
SIC: 2836 Biological Products, (No Diagnostic Substances)